glp-1 shortness of breath receptor agonists You might be losing more
Description
A Video Clip below on the barriers of a woman scientist to push Novo Nordisk to develop GLP-1 for obesity
J Nucl Med Technol
Addictive substances typically cause supraphysiological dopamine release in the nucleus accumbens, reinforcing drug-seeking behaviour
10.1093/toxsci/kfx018 291
Sci Rep (2018) 8(1):6192
